Primary laryngeal carcinosarcoma is a rare type of malignancies, and the standard therapeutic protocol for its treatment has yet to be established. This retrospective study analyzed the clinical and pathological characteristics, risk factors, treatment options, and prognosis of 13 patients with primary laryngeal carcinosarcomas. This case series included 11 males and 2 females with an age range from 32 to 78 years at diagnosis. The initial clinical symptoms included hoarseness, dyspnea, and foreign body sensation in the throat. The primary tumor sites were at the glottis, supraglottis, and larynx. All these patients were active or passive smokers, and more than half of them were alcohol addictive. The surgical treatment for laryngeal carcinosarcomas included CO2 laser surgery in seven cases, partial laryngectomy and neck dissection in three cases, and total laryngectomy and neck dissection in three cases. Among them, seven cases received postoperative radiotherapy. After follow-upwith amean of 31.15-month, four cases died. Primary laryngeal carcinosarcoma is a rare butmore aggressive malignancy. Contralateral lymph nodemetastasis can occur at the early stage of this disease. A treatment combining surgery and postoperative radiotherapy is strongly recommended.
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|3 区生物
小类|3 区生物工程与应用微生物4 区医学:研究与实验
最新[2023]版:
无
JCR分区:
出版当年[2017]版:
Q2BIOTECHNOLOGY & APPLIED MICROBIOLOGYQ3MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q3BIOTECHNOLOGY & APPLIED MICROBIOLOGYQ3MEDICINE, RESEARCH & EXPERIMENTAL
第一作者机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China[2]Capital Med Univ, Minist Educ, Key Lab Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China[3]Key Lab Mol Pathol Head & Neck, Beijing 100730, Peoples R China
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China[2]Capital Med Univ, Minist Educ, Key Lab Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China[3]Key Lab Mol Pathol Head & Neck, Beijing 100730, Peoples R China
推荐引用方式(GB/T 7714):
Zhang Yang,Huang Zhigang,Gross Neil,et al.Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single Hospital[J].BIOMED RESEARCH INTERNATIONAL.2019,2019:doi:10.1155/2019/1754675.
APA:
Zhang, Yang,Huang, Zhigang,Gross, Neil,Fang, Jugao,Chen, Xiaohong...&Zhong, Qi.(2019).Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single Hospital.BIOMED RESEARCH INTERNATIONAL,2019,
MLA:
Zhang, Yang,et al."Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single Hospital".BIOMED RESEARCH INTERNATIONAL 2019.(2019)